Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 7.98 is 48% below its 5-year average of 15.42, near the low end of its 5-year range (7.98–31.66).
As of the fiscal period ended Tuesday, June 30, 2026. 38.16% below its 12-month average of 12.91.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.98.
CURRENT RATIO
7.98
CURRENT RATIO AVG TTM
12.91
CURRENT RATIO AVG 3Y
13.45
CURRENT RATIO AVG 5Y
15.42
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-38.16%
CURRENT VS 3Y AVG
-40.65%
CURRENT VS 5Y AVG
-48.23%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+112.27%
vs the sector median at left
Market Cap
$169.53M
Current Ratio
1.59
TTM Avg
1.58
3Y Avg
1.42
5Y Avg
1.43
Market Cap
$159.80M
Current Ratio
20.14
TTM Avg
22.07
3Y Avg
21.46
5Y Avg
19.43
Market Cap
$171.13M
Current Ratio
12.82
TTM Avg
9.83
3Y Avg
6.43
5Y Avg
5.45
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nkarta, Inc. (NKTX) | $165.27M | 7.98 | 12.91 | 13.45 | 15.42 |
| OptimizeRx Corp. (OPRX)vs › | $165.32M | 5.58 | 2.96 | 5.18 | 6.05 |
| Cue Biopharma, Inc. (CUE)vs › | $168.10M | 1.25 | 2.29 | 3.57 | 4.16 |
| Quanterix Corporation (QTRX)vs › | $162.04M | 3.40 | 5.75 | 8.37 | 8.52 |
| MediWound Ltd. (MDWD)vs › | $168.92M | 2.32 | 2.15 | 3.17 | 2.88 |
| Journey Medical Corporation (DERM)vs › | $169.53M | 1.59 | 1.58 | 1.42 | 1.43 |
| Minerva Neurosciences, Inc. (NERV)vs › | $159.80M | 20.14 | 22.07 | 21.46 | 19.43 |
| PepGen Inc. (PEPG)vs › | $159.78M | 13.36 | 9.68 | 8.92 | 10.26 |
| Precision BioSciences, Inc. (DTIL)vs › | $171.13M | 12.82 | 9.83 | 6.43 | 5.45 |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | 0.90 | 1.03 | 0.91 | 1.08 |
Current Ratio
7.98
Quick Ratio
7.98
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 7.98 |
| 2026-03-31 | 12.96 |
| 2025-12-31 | 12.69 |
| 2025-09-30 | 15.23 |
| 2025-06-30 | 15.67 |
| 2025-03-31 | 14.48 |
| 2024-12-31 | 14.45 |
| 2024-09-30 | 12.91 |
| 2024-06-30 | 15.91 |
| 2024-03-31 | 19.95 |
| 2023-12-31 | 10.85 |
| 2023-09-30 | 10.97 |
| 2023-06-30 | 10.77 |
| 2023-03-31 | 12.79 |
| 2022-12-31 | 16.36 |
| 2022-09-30 | 15.17 |
| 2022-06-30 | 31.66 |
| 2022-03-31 | 20.59 |
| 2021-12-31 | 18.99 |
| 2021-09-30 | 21.96 |
| 2021-06-30 | 27.68 |
| 2021-03-31 | 32.31 |
| 2020-12-31 | 36.10 |
| 2020-09-30 | 34.88 |
| 2020-06-30 | 0.37 |
| 2020-03-31 | 2.83 |
| 2019-12-31 | 4.56 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
